Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Post-mastectomy Wound Drainage
NCT05682209Phase 4Completed
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of Octreotide long-acting injection in Seroma. Started Dec 2020; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
Seroma
Beyond the preview
Go deeper on NCT05682209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05682209.